Culture

Periodontitis: Researchers search for a new active substance

Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralise only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the Journal of Biological Chemistry.

Periodontitis is a common bacterial inflammation of the gums. According to the World Health Organization WHO Oral Health Study, almost 10 percent of the global population are affected with a severe form of the disease, which can lead to tooth loss as well as increasing the risk of other diseases, such as Alzheimer's and cardiovascular disease. Until now, treatment has mainly involved the use of broad-spectrum antibiotics that attack all bacteria in the mouth. However, this has some disadvantages: "One side effect of the treatment is that it also destroys all the harmless or beneficial bacteria in the oral cavity. In addition, the bacteria can ultimately develop resistance to the antibiotics," explains Dr Mirko Buchholz from Periotrap Pharmaceuticals, who led the new study alongside Professor Milton T. Stubbs, a biotechnologist at MLU.

The researchers therefore looked for a way to eradicate only the harmful bacteria in the mouth. A team from Fraunhofer IZI's Department of Drug Design and Target Validation in Halle developed a test substance that attacks glutaminyl cyclase, a specific enzyme in the bacteria that plays a special role in metabolism. Inactivation of this enzyme harms the bacteria and, ideally, no periodontitis can develop. To test its effectiveness, the researchers joined forces with the Clinics for Dental Medicine at the University of Bern, Jagiellonian University in Krakow and the University of Louisville in Kentucky (USA). They found that the new substance successfully suppresses the growth of pathogenic bacteria.

The new test substance has a special feature: It only works on the harmful bacteria. "Our target, glutaminyl cyclase, comes in two different variants. Normally, plants and bacteria have one variant of the enzyme and mammals another. The two variants work in a similar fashion, but they differ significantly in their structure. It's a bit like flat-tip versus Phillips screwdrivers," explains Stubbs. Surprisingly, the bacteria that trigger periodontitis have the mammalian variant of the enzyme. "This is crucial for our approach because it gives us a possible target so we only kill the pathogenic bacteria and leave the harmless ones intact," says Mirko Buchholz. To minimise possible side effects in advance, the team compared the bacterial enzyme with the human variant. "There are small but significant differences between the enzymes," says Stubbs. These differences are probably sufficient for the new substance to not affect the human enzymes. Therefore, only minor side effects are to be expected.

The researchers' study provides initial evidence that the approach essentially works. It must now be fine-tuned in further studies and tested in subsequent clinical trials. It may therefore take some years before the research from Halle becomes a marketable drug.

Credit: 
Martin-Luther-Universität Halle-Wittenberg

SARS-CoV-2 variant that emerged in UK more transmissible; could spark resurgences

A variant of SARS-CoV-2 that emerged in southeast England in November 2020 is more transmissible than pre-existing variants, a new modeling study finds. Further analyses suggest the variant - VOC 202012/01 - will lead to large resurgences of COVID-19 cases. "Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalizations and deaths across England in 2021 will exceed those in 2020," the study's authors say. After emerging in November 2020, evidence began to emerge in December that VOC 202012/01 was rapidly outcompeting preexisting variants in southeast England. As of 15 February 2021, it comprises roughly 95% of new SARS-CoV-2 infections in England and has now been identified in at least 82 countries. Estimates of its growth rate, disease severity, and impact are crucial for informing policy responses. After analyzing 150,000 sequenced SARS-CoV-2 samples from across the United Kingdom, Nicholas Davies and colleagues found that the relative population growth rate of VOC 202012/01 in the first 31 days following its initial observation was higher than that of all 307 other virus variant lineages. To understand possible biological mechanisms for this, the authors used an age- and regionally structured mathematical model of SARS-CoV-2 transmission to test several assumptions, including that the variant has a higher viral load or longer shedding period. Based on their analysis, they identify increased transmissibility as the model that best explains the variant's rapid spread. They estimate that the novel variant has a 43-90% higher reproduction number than preexisting variants of SARS-CoV-2 in England. Davies and colleagues used modeling to further analyze how interventions could reduce the potential burden of this new variant in the United Kingdom. From the scenarios they assessed, they conclude that a substantially increased vaccine roll-out and school closures for 2021 may be needed to prevent COVID-19 deaths and hospitalizations in 2021 from exceeding those in 2020. The authors note limitations to their analysis, including having only considered a small number of intervention and vaccination scenarios. Even so, they conclude, their projections point to "an urgent need to consider what new approaches may be required to sufficiently reduce the ongoing transmission of SARS-CoV-2."

Credit: 
American Association for the Advancement of Science (AAAS)

Study links kidney stones with bone problems

In an analysis of nationwide data from the Veterans Health Administration, approximately one-quarter of individuals with kidney stones had a diagnosis of osteoporosis or bone fracture around the time of their kidney stone diagnosis. The findings are published in the Journal of Bone and Mineral Research.

Investigators identified 531,431 patients with kidney stone disease between 2007 and 2015, and they found that 23.6% of patients had a diagnosis of osteoporosis or fracture around the time of their kidney stone diagnosis. In patients with no prior history of osteoporosis or bone analyses before their kidney stone diagnosis, 9.1% received a bone density scan after a kidney stone diagnosis, of whom 20% were subsequently diagnosed with osteoporosis.

The findings provide support for wider use of bone density screening in individuals with kidney stones, including middle-aged and older men who may not be recognized as at-risk for osteoporosis or fracture.

"We hope this work raises awareness regarding the possibility of reduced bone strength in patients with kidney stones. In our future work, we hope to identify which patients with kidney stones are at higher risk for osteoporosis or fracture to help guide bone density screening efforts by clinicians in this population," said lead author Calyani Ganesan, MD, of Stanford University.

Credit: 
Wiley

When should patients with dementia receive palliative care?

Patients with dementia may benefit from being referred to specialist palliative care--a branch of medicine that focuses on optimizing quality of life and providing relief from symptoms--but who should be referred, and when? A recent analysis of published studies on the topic found a lack of consensus regarding referral criteria for palliative care in patients with dementia. The results are published in the Journal of the American Geriatrics Society.

The analysis identified a wide array of reasons for referring patients with dementia to specialist palliative care, broadly classified under 13 themes. The diversity highlights the many reasons to involve specialist palliative care and simultaneously the lack of consensus on when patients should be referred.

"Given the growing recognition of unmet supportive and palliative care needs in patients with dementia, a set of consensual referral criteria may facilitate timely specialist palliative care referral to enhance patient and caregiver outcomes," said senior author David Hui, MD, MSc, of the University of Texas MD Anderson Cancer Center.

Credit: 
Wiley

Study examines motives for dropping out of higher education

Students have diverse reasons for dropping out of colleges and universities without obtaining a degree. A new study published in the European Journal of Education provides a detailed analysis of these reasons.

The study found that the most important reasons for leaving university without a degree are mainly related to students' lack of interest in their field of study, as well as wrong expectations concerning the content of their studies. Problems related to students' academic performance also appear to be important.

The study suggests potential counter measures that higher education institutions might use to help students at risk of dropping out as they strive to finish their education and obtain their degrees.

"The phenomenon of university dropout is a very relevant issue, and it's extremely important for the society, for higher education institutions, and of course, for the students themselves. It's associated with an inefficient use of universities' resources, personal failure, wasted time, and monetary investments," said co-author Hervé D. Teguim Kamdjou, MSc, of the University of Duisburg-Essen, in Germany. "Providing new insights into this issue will help universities implement early warning systems and more personalised counselling services to support students at risk of dropping out during an early stage of study."

Credit: 
Wiley

Impacts of the COVID-19 pandemic on mammals at tourist destinations

How have travel restrictions and reduced tourism in response to the COVID-19 pandemic affected mammals in different tourist destinations? Researchers recently reviewed published studies and news stories to consider this question. Their findings are published in Mammal Review.

The authors noted that whether the pandemic has affected mammals positively or negatively is difficult to determine--their findings showed that effects of reduced tourism varied by species and the contexts that they are in.

For example, some mammals in zoos thrived in the absence of visitors while others appeared to be deprived of enrichment without tourists. Also, the pandemic brought hunger to some mammals that had been offered food by tourists, and the absence of tourism may have put some animals in protected areas in danger of being poached. On the other hand, marine mammals have reportedly returned to environments that were too polluted and disturbed to live in before the pandemic but now provide suitable habitat.

Credit: 
Wiley

Researchers offer new insights on bird migration

image: In a new study published in the Journal of Biogeography, investigators used modelling and tracking techniques to identify potential migratory barriers and corridors within the Indo-European flyway, as well as birds' adaptive behaviors that help with navigation along the route.

Image: 
Benjamin Metzger

During their seasonal migration, birds typically travel between breeding and non-breeding grounds along migratory routes grouped into major flyways, such as the Indo-European flyway between Europe and the Indian subcontinent. In a new study published in the Journal of Biogeography, investigators used modelling and tracking techniques to identify potential migratory barriers and corridors within the Indo-European flyway, as well as birds' adaptive behaviors that help with navigation along the route.

"For me, the study started years ago on the coast of the German Baltic Sea. Together with two of my co-authors Roland Neumann and Benjamin Metzger, we caught and tracked Common rosefinches aiming to reveal their exact wintering locations," said lead author Simeon Lisovski, PhD, of the Alfred Wegener Institute Helmholtz Centre for Polar and Marine Research, in Germany. "Years later, we found out that other researchers from across Europe did the same and that putting the tracks in perspective can yield more in-depth ecological insights than each single study could provide. Merging these tracks with flyway-wide datasets on climate and habitat has been a super insightful and exciting collaborative experience."

Credit: 
Wiley

Opioid overdose reduced in patients taking buprenorphine

image: Laura Bierut was one of the senior investigators who studied buprenorphine treatment for opioid use disorder in patients who also take benzodiazepines -- drugs that treat anxiety and similar conditions. Her team at Washington University School of Medicine in St. Louis studied overdose risk in people taking buprenorphine and found that the drug lowered risk, even in people who also took benzodiazepines.

Image: 
Washington University

Even during the COVID-19 pandemic, opioid misuse has continued unabated in the United States, with an estimated 2.5 million or more Americans suffering from opioid use disorder. Most people treated for the disorder are given medications, such as buprenorphine, that activate opioid receptors. But there is disagreement about whether it's safe to prescribe buprenorphine for people who also take benzodiazepines, which are potentially addictive medications prescribed for stress, sleep and anxiety.

New research involving the medical data of more than 23,000 patients being treated for opioid use disorder supports the use of buprenorphine in patients also taking benzodiazepines. Researchers at Washington University School of Medicine in St. Louis found that the drug can protect opioid users from overdosing, even when such patients also take benzodiazepines, such as Valium, Xanax and Ativan.

The study is published online March 3 in The American Journal of Psychiatry.

"Buprenorphine has had very good results as a treatment for opioid use disorder, partly because patients can take the drug at home, which is different from other drugs commonly used to treat the disorder such as methadone, which requires visits to clinics," said first author Kevin Xu, MD, a resident physician in the Department of Psychiatry. "It's well known that buprenorphine saves lives in patients with opioid use disorder, but because the drug has central nervous system depressing effects, there have been big questions about safety when patients also take benzodiazepines, which also depress the central nervous system. Our findings, however, indicate that buprenorphine makes overdose less likely, even in people also taking benzodiazepines."

The research team dug into the topic partly because many treatment centers do not accept patients who are addicted to opioids and also take prescription benzodiazepines.

"Up to a third of people who suffer opioid overdoses also have benzodiazepines in their systems," Xu said. "Many people get turned away from buprenorphine treatment or, even worse, their doctors abruptly taper them off benzodiazepines, which can be very destabilizing. Our goal was to learn more about whether there are dangers associated with taking buprenorphine while also taking benzodiazepines."

Although buprenorphine isn't the only medication used to treat opioid use disorder -- others include methadone and naltrexone -- the researchers focused on buprenorphine in this study because patients often can fill prescriptions for the medication at a pharmacy and take the drug at home.

Xu and his colleagues -- including Laura J. Bierut, MD, the Alumni Endowed Professor of Psychiatry, and Richard A. Grucza, PhD, a professor in the Department of Family and Community Medicine at Saint Louis University -- analyzed data compiled by insurance companies that tracked emergency room visits involving 23,036 de-identified patients with buprenorphine prescriptions.

"We've all heard about the devastation caused by opioids such as heroin and fentanyl, but use of benzodiazepines also can be addictive and deadly," said Bierut, one of the study's senior investigators. "Many people who are addicted to opioids also have anxiety or depression for which they've been prescribed a benzodiazepine drug. How to handle that combination has confounded psychiatrists and addiction medicine specialists, but we think these findings provide some clarity."

Every de-identified patient tracked in the database had experienced at least one overdose event, but none suffered a fatal overdose. Each individual was followed for two years to track what prescriptions they filled and how often each person ended up in the emergency department with a drug-related poisoning. Although the database tracked only nonfatal overdoses, Xu explained those events account for the vast majority of drug-related poisonings, adding that those who suffer nonfatal overdoses are at risk to eventually die of a drug overdose.

"These are high-risk patients, and we know that when someone overdoses once, it's likely he or she will be back in an emergency department again for the same reason," Xu said.

In trying to learn whether buprenorphine helped prevent overdoses and whether taking that drug along with benzodiazepines might increase overdose risk, the researchers discovered that opioid users who took buprenorphine had a 40% reduction in their risk for an overdose compared with not receiving the treatment. Meanwhile, opioid users with benzodiazepine prescriptions who did not take buprenorphine were almost twice as likely to suffer an overdose that put them in the hospital.

"Even for people taking benzodiazepines, buprenorphine had a protective effect," Xu said. "Buprenorphine didn't protect those patients from overdose as much as it protected users not taking benzodiazepines, but it still made overdoses less likely."

What that means about drug interactions between buprenorphine, opioids and benzodiazepines still isn't completely clear. But what is clear, Xu said, is that prescribing buprenorphine for opioid users in treatment can protect them from overdose, even if they also are taking a benzodiazepine drug.

Credit: 
Washington University School of Medicine

Do marketers matter for entrepreneurs?

Researchers from the University of Texas, University of Chicago, University of Notre Dame, and London School of Economics published a new paper in the Journal of Marketing that examines whether entrepreneurs in emerging markets can benefit from marketers' help.

The study, forthcoming in the Journal of Marketing, is titled "Do Marketers Matter for Entrepreneurs? Evidence from a Field Experiment in Uganda" and is authored by Stephen Anderson, Pradeep Chintagunta, Frank Germann, and Naufel Vilcassim.

Can marketers help improve the world? While this question may seem vast and unknowable, this new study proposes otherwise. The researchers propose that marketers can help entrepreneurs in emerging markets grow their businesses. And flourishing entrepreneurs in these markets can then improve lives, sustain livelihoods, enhance overall living standards, and strengthen societies.

Entrepreneurs are ubiquitous in emerging markets. In 2010, more than 31% of the adult population in Uganda, the setting for the study, was either starting a business or running a business less than four years old. However, many emerging market entrepreneurs struggle to make ends meet and their firms' growth rates are low, stifling the positive impact they could have on society. The low growth rates seem to result from most businesses being undifferentiated and failing to attract customer interest.

Marketing helps firms differentiate by attempting to answer the question, "Why should the customer buy from the firm and not elsewhere?" Thus, we examine whether entrepreneurs in emerging markets can benefit from marketers' help.

To test marketers' effect on emerging market entrepreneurs, the researchers conducted a randomized controlled field experiment with 930 Ugandan businesses. The experiment allowed them to examine the impact of a business support intervention in which international professionals from varying functional backgrounds (e.g., marketing, consulting) volunteered time to help small-scale entrepreneurs. Results show volunteer marketers are effective at helping entrepreneurs grow sales, profits, assets, and employees. Specifically, compared to control firms, the entrepreneurs supported by volunteer marketers grew monthly sales by 51.7% on average, while their monthly profits improved by 35.8%, total assets increased by 31.0%, and paid employees rose by 23.8%. An analysis of interactions between volunteers and entrepreneurs indicates the marketers spent more time on product-related topics than other volunteers during the intervention. Furthermore, analyses indicate the marketers helped the entrepreneurs focus on premium products to differentiate in the marketplace. As Anderson explains, "Because small-scale businesses form the commercial backbone of most emerging markets, their performance and development are critically important. And marketers' positive impact on the businesses highlights the need for the field's increased presence in emerging markets. "

Chintagunta continues that "Given the positive and direct impact marketers can have on growth outcomes, we hope our study will motivate marketing practitioners to work with entrepreneurs and early-stage ventures in emerging markets." Governmental and non-governmental organizations actively serving emerging markets should also benefit from our findings when designing and implementing future business support services. Entrepreneurs should also take note of our findings and solicit marketers' help. Finally, business schools could incorporate versions of this 'remote coaching' intervention into their emerging market programs with a focus on matching entrepreneurs with their marketing students. Multinationals can participate in future remote marketing coaching interventions like this, too. "This endeavor, we believe, could be a win-win for the entrepreneurs and the multinationals: The entrepreneurs' businesses would likely grow and the multinationals would likely have more satisfied employees, accrue corporate social responsibility-related benefits, and learn about opportunities (and threats) that exist in emerging markets" says Germann.

Credit: 
American Marketing Association

Custom diets are essential to mental health, new research shows

BINGHAMTON, NY -- Customized diets and lifestyle changes could be key to optimizing mental health, according to new research including faculty at Binghamton University, State University of New York.

"There is increasing evidence that diet plays a major role in improving mental health, but everyone is talking about a healthy diet," said Begdache, an assistant professor of health and wellness studies at Binghamton University and co-author of a new paper in Nutrients.

"We need to consider a spectrum of dietary and lifestyle changes based on different age groups and gender," she said. "There is not one healthy diet that will work for everyone. There is not one fix."

Begdache, who is also a registered dietitian, believes that mental health therapies need to consider the differences in degree of brain maturity between young (18-29 years old) and mature (30 years or older) adults, as well as the brain morphology among men and women.

She and her research team conducted an online survey to examine food intake, dietary practices, exercise and other lifestyle factors in these four subpopulations. Over a five-year period (2014-19), more than 2,600 participants completed the questionnaire after responding to social media posts advertising the survey. The team collected data at different timepoints and seasons and found important dietary and lifestyle contributors to mental distress -- defined as anxiety and depression -- in each of the groups.

Key findings of this study:

Significant dietary and lifestyle approaches to improve mental well-being among young women include daily breakfast consumption, moderate-to-high exercise frequency, low caffeine intake and abstinence from fast food.

Dietary and lifestyle approaches to improve mental well-being among mature women include daily exercise and breakfast consumption, as well as high intake of fruits with limited caffeine ingestion.

To improve mental well-being of young men, dietary and lifestyle approaches include frequent exercise, moderate dairy consumption, high meat intake, as well as low consumption of caffeine and abstinence from fast food.

Dietary approaches to improve mental well-being among mature men include moderate intake of nuts.

Begdache and her team split the respondents into two age groups because human brain development continues into the late 20s. For young adults of both genders, quality of diet appears to have an impact on the developing brain.

"Young adults are still forming new connections between brain cells as well as building structures; therefore, they need more energy and nutrients to do that," Begdache said.

As a result, young adults who consume a poor-quality diet and experience nutritional deficiencies may suffer from a higher degree of mental distress.

Age is also the reason high caffeine consumption was associated with mental distress in both young men and young women.

"Caffeine is metabolized by the same enzyme that metabolizes the sex hormones testosterone and estrogen, and young adults have high levels of these hormones," Begdache said. "When young men and women consume high levels of caffeine, it stays in their system for a long time and keeps stimulating the nervous system, which increases stress and eventually leads to anxiety."

The team also split respondents based on biological sex, since brain morphology and connectivity differ between men and women. Put simply, the male brain is "wired" to enable perception and coordination, whereas the female brain is built to support analysis and intuition. Begdache and her team believe these differences may influence nutritional needs.

"I have found it in my multiple studies so far, that men are less likely to be affected by diet than women are," said Begdache. "As long as they eat a slightly healthy diet they will have good mental well-being. It's only when they consume mostly fast food that we start seeing mental distress.

"Women, on the other hand, really need to be consuming a whole spectrum of healthy food and doing exercise in order to have positive mental well-being," she added. "These two things are important for mental well-being in women across age groups."

According to Begdache, current recommendations for food intake are all based on physical health; there are no recommendations for mental health. She hopes that will change -- and that her work will play a role in making those changes.

"I hope to see more people doing research in this area and publishing on the customization of diet based on age and gender," she said. "I hope that one day, institutions and governments will create dietary recommendations for brain health."

Credit: 
Binghamton University

The Lancet Child & Adolescent Health: First global study of pandemic's impact on childhood cancer care reveals worldwide effects

More than three quarters (78%) of hospitals surveyed between June and August 2020 reported that their paediatric cancer care had been affected by the pandemic.

Almost half (43%) made fewer new cancer diagnoses than expected, while around one third (34%) noted a rise in the number of patients abandoning treatment.

Nearly one in ten (7%) closed their paediatric cancer units completely at some stage during the pandemic.

Hospitals in low- and middle-income countries (LMICs) were disproportionately affected, with unavailability of chemotherapy, treatment abandonment, and disrupted radiotherapy among issues more frequently reported.

The COVID-19 pandemic has had major impacts on childhood cancer care worldwide, according to a survey of more than 300 clinicians from 200 hospitals worldwide published in The Lancet Child & Adolescent Health journal.

The first global assessment of the impact of COVID-19 on paediatric cancer care reveals that paediatric cancer care was affected at more than three quarters of surveyed hospitals (78%).

Almost half (43%) reported diagnosing fewer new cases than expected, while around one third (34%) reported a rise in the number of patients who abandoned treatment. The survey also found that nearly one in ten (7%) closed their paediatric cancer units completely at some stage during the pandemic. Of the 15 units that closed, 13 (87%) were in LMICs, and mean closure time was 10 days.

COVID-19 has placed huge pressures on hospitals and healthcare systems around the world. Previous studies have reported delays in the presentation and care of paediatric cancer patients during the pandemic at the national or regional level. The survey published today adds the views of health care workers from around the world on the care their hospitals are able to deliver.

Daniel Moreira, M.D., of St. Jude Children's Research Hospital, USA, said: "Our findings suggest that COVID-19 has had a greater impact on childhood cancer care globally than single-region studies had suggested, with centres in LMICs particularly hard hit. Hospitals in LMICs were under strain even before the pandemic, with fewer resources and less access to care for children with cancer, so our results seem to reflect the relative strength of different healthcare systems around the world." [1]

Wide-ranging impacts were identified worldwide, including reductions in available clinical staff, paediatric cancer beds and personal protective equipment (PPE). However, the results suggest the effects in LMICs were more pronounced, with changes to chemotherapy due to treatment agent shortages, treatment abandonment, and disruptions to radiotherapy among issues frequently reported.

The authors of the new study assessed the global impacts of COVID-19 on childhood cancer care by designing a cross-sectional survey that was distributed to hundreds of healthcare workers worldwide through international and regional networks. The survey covered the period from June 22nd to August 21st, 2020, and included a range of questions to assess hospital characteristics, the number of patients diagnosed with COVID-19, and disruptions and adaptations to cancer care.

The survey was completed by 311 healthcare workers at 213 institutions in 79 countries. Countries were grouped as low-income, lower middle-income, upper middle-income, and high-income. Responses were analysed at the institutional level.

Most hospitals (83%) were in LMICs and the vast majority (88%) were able to test for COVID-19. The authors found that effects of the pandemic on paediatric cancer care were largely independent of the number of COVID-19 cases in individual hospitals or at national levels.

The findings suggest that paediatric cancer care globally has been affected by COVID-19, with more than three quarters of hospitals (78%) reporting some impact on their capacity to provide care.

Considerable disruption to cancer diagnosis was reported, with almost half of hospitals (43%) diagnosing fewer new cases than expected. Effects on hospitals' ability to provide cancer treatment were also noted, with one in three (34%) reporting a rise in the numbers of patients whose therapy did not begin or was delayed by four weeks or longer - known as treatment abandonment.

Several impacts on the management of paediatric cancer were reported, including a reduction in surgery at most hospitals (79%). More than half noted shortages in blood products, while a similar proportion modified chemotherapy because of treatment agent shortages (60% and 57%, respectively). Disruption to radiotherapy was also considerable, with almost one third (28%) reporting treatment disruption.

Hospital resources were significantly affected, with one third (32%) noting decreased financial support, while two thirds (66%) reported a reduction in available clinical staff. Around one in five hospitals (19%) noted a reduction in availability of paediatric cancer beds.

Nearly one in ten hospitals (7%) had to close their paediatric cancer unit completely at some point, with an average period of closure of 10 days. The vast majority of these (87%) were in LMICs, and while some impacts on paediatric cancer care did not vary based on country income level, LMICs were disproportionately affected in a number of areas.

This included changes to chemotherapy due to treatment agent shortages (40%, 45%, and 40% for low-income, lower middle-income, upper middle-income countries, respectively, compared with 11% for high-income), higher rates of treatment abandonment (38%, 52%, and 33% for low-income, lower middle-income, upper middle-income, respectively, compared with 8% for high-income), and more frequent disruptions to radiotherapy (78%, 68%, and 46% for low-income, lower middle-income, upper middle-income, respectively, compared with 10% for high-income).

Hospitals in LMICs also reported decreased access to life-saving interventions more frequently (8%, 33%, and 16% for low-income, lower middle-income, upper middle-income, respectively, compared with 3% for high-income), and unexpected deaths (31%, 36%, and 13% for low-income, lower middle-income, upper middle-income, respectively, compared with 8% for high-income).

Hospitals in LMICs were also more likely to report decreases in their usual government funding for cancer care (15%, 52%, and 31% for low-income, lower middle-income, upper middle-income, respectively, compared with 8% for high-income).

Dylan Graetz, M.D., of St. Jude Children's Research Hospital, USA, said: "The long-term impacts on childhood cancer outcomes are not yet clear. Our findings highlight the need for ongoing assessment of resource needs during the pandemic and the sharing of successful strategies to tackle the negative effects on paediatric cancer care." [1]

Most hospitals put in place new policies and guidelines to support paediatric cancer care during the pandemic, with more than two thirds (69%) using new or adapted patient and staff safety checklists, while new processes for communication with patients and families (63%) and new guidance on essential services (56%) were also common. The authors found that many of these were well received by hospital staff and may be beneficial beyond the pandemic.

Professor Laila Hessissen, of Mohammed V University, Morocco, said: "Although the COVID-19 pandemic has created additional barriers to childhood cancer care, we have proven we are a resilient community and can translate some of the adaptations forced by the pandemic to the future of cancer care." [1]

The authors note a number of limitations. The survey results reflect only the knowledge and opinions of respondents at one stage during a fast-changing pandemic. As the survey was in English and distributed within two paediatric oncology networks, the results may not be generalizable to small, low-resource settings where staff do not speak English and are not part of these networks. The survey covered a range of topics and took around 60 minutes to complete, which may have caused survey fatigue leading to relatively high number of incomplete responses. Nonetheless, the authors believe this study captured a comprehensive description of the global effect of this pandemic on paediatric oncology care.

This report is part of the COVIMPACT study, which aims to capture the effects of the COVID-19 pandemic on paediatric cancer care. Furthermore, this work is linked to The Global COVID-19 Observatory and Resource Center for Childhood Cancer (covid19childhoodcancer.org), a collaboration of St. Jude Children's Research Hospital and the International Society of Paediatric Oncology (SIOP).

Writing in a linked Comment, Dr Soad Fuentes-Alabi, of Ayúdame a Vivir Foundation Medical Center, and National Children's Hospital Benjamin Bloom, El Salvador, says studies such as this emphasise the challenges of delivering childhood cancer care in LMICs during public health emergencies: "In low-income and middle-income countries, including in Latin America, the common issues of late diagnosis and treatment abandonment or interruptions have worsened during the pandemic."

Credit: 
The Lancet

Influenza vaccine produces protective antibodies against diverse flu strains in animals

A series of nanoparticle-based vaccines elicits protective antibodies against various strains of the influenza virus in nonhuman primates, according to work from Nicole Darricarrère and colleagues. Although more research is needed, the vaccines mark an important step toward a universal flu vaccine for humans, which has long been a major goal for infectious disease researchers. Current seasonal flu vaccines can prevent disease but often only work for a year, after which a new vaccine must be developed. This occurs because influenza viruses evolve extremely quickly, meaning that a year-old vaccine may not prepare the immune system to recognize a new strain. A universal vaccine that could remain effective year-to-year would represent a major medical accomplishment but creating such a vaccine has been challenging. However, scientists theorize that a universal vaccine might work if it incorporated key proteins on the surface of the influenza virus that remain constant during evolution, such as those that allow the virus to enter cells. Based on this strategy, Darricarrère et al. tested influenza vaccines that use nanoparticles to deliver modified forms of hemagglutinin (HA) influenza virus surface proteins and an emulsion vaccine adjuvant. When given to nonhuman primates, the vaccines stimulated the production of protective antibodies against multiple H1 and H3 influenza A viruses - the ones most likely to cause pandemics. Furthermore, the antibodies were potent and recognized viruses in a similar way as human antibodies, suggesting the vaccines might provide broad immunity. Darricarrère et al. note that although their study didn't evaluate the durability of vaccine responses, their vaccines are also currently being tested in early clinical trials.

Credit: 
American Association for the Advancement of Science (AAAS)

Albumin provides no benefit to hospitalized patients with advanced liver disease

Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above 'standard care', finds a large-scale multicentre trial led by UCL researchers.

Albumin is a protein made in the liver that prevents fluid leaking from the bloodstream to other body tissues and carries various substances throughout the body, such as hormones or enzymes. In people with liver disease, low albumin levels are associated with an increased risk of death among hospitalised patients who have cirrhosis, and laboratory studies have shown albumin to have an anti-inflammatory effect. Therefore, albumin infusions are considered the best fluid for patients with cirrhosis and are an integral part of clinical care.

Explaining the ATTIRE* trial, Principal Investigator, Professor Alastair O'Brien (UCL Division of Medicine) said: "Acutely hospitalised patients with cirrhosis are very ill; infection and increased systemic inflammation lead to very high rates of death in those affected.

"Albumin infusions have been used with great enthusiasm by liver specialists for 70 years, are widely believed to be the best at reducing abnormal fluid build-up caused by cirrhosis and preclinical studies support an anti-inflammatory role. However, albumin is considerably more expensive than other fluids, shortages in production do occur and, crucially, confirmatory large-scale clinical trials to support use are lacking.

"To establish a better evidence base, we examined whether increasing a serum albumin level of 30 g/L or greater in these patients with repeated daily infusions of human albumin solution, compared with standard UK albumin use, would reduce the incidences of infection, kidney dysfunction, and death."

In the ATTIRE trial, published in the New England Journal of Medicine, 777 patients hospitalised with acute decompensated liver cirrhosis, were randomly placed in one of two groups. The trial was conducted across 35 UK sites and alcohol was the primary cause of cirrhosis in 90% of patients.

In the experimental arm of the study, known as the 'targeted albumin group', 380 patients were given daily infusions of human albumin solution to raise the concentration in the blood to 30 grams of albumin per litre or greater, for up to 14 days or until discharge.

In the other group, 397 patients were given 'standard care', which could include albumin infusions for draining ascites (fluid in the abdomen) or renal failure, for up to 14 days or until discharge. Standard care varies per patient, is based on a clinician's judgement, and the levels of albumin prescribed are far lower than the study's experimental arm.

The targeted albumin group received about 10 times more albumin and serum albumin levels rose to 30 grams per litre or greater within three days in this group, whereas levels remained at 25 grams per litre or lower in the standard care group. To establish if the targeted albumin treatment had worked, the trial's primary end point was; infection, renal failure or death between days 3 and 15 after initiation of treatment.

Findings

In the targeted albumin group, 113 of 380 patients (29.7%) developed one of the primary end points: infection, renal dysfunction or death. In the standard care group it was 120 of 397 patients (30.2%). Across all hospitalised patients one third (32.3%) had died within six months of initiating treatment.

Researchers concluded there is no evidence of benefit for targeted albumin. In addition, more severe or life-threatening serious adverse events (i.e. pulmonary edema or ascites) occurred in those patients in the targeted albumin group.

Professor O'Brien, also Clinical Director of the UCL Comprehensive Clinical Trials Unit, added: "Our large, high quality, randomised trial showed no benefit for targeted albumin infusions and those given higher doses, in fact, had more serious adverse events. These data strongly support both the need to abandon the use of this costly therapy, and a reappraisal of our understanding of this complex condition. Finally, the high mortality in these patients does not appear to have changed in 20 years. This calls for a renewed focus on preventing the major causes of liver disease, excessive alcohol consumption and obesity."

Liver cirrhosis

Liver disease is the fifth commonest cause of death in the UK and the only one of the top 10 currently rising, predominantly as a consequence of excess alcohol consumption and increasing levels of obesity.

Around 70,000** people are admitted every year to hospitals in England with liver disease, and of those approximately 22,000** admissions are alcoholic liver disease and this figure continues to rise.

It is estimated that around 9,000*** people die from cirrhosis in the UK each year. Average survival for people with decompensated (advanced) cirrhosis is two years. A common cause of death is infection as patients have a weakened immune system, yet no effective strategy exists to improve this.

The condition places a high demand on the health service with frequent admissions to hospital for management of ascites (abnormal fluid build-up in the abdomen) and other complications such as internal bleeding and brain complications such as encephalopathy.

Researchers from the UCL Institute for Liver and Digestive Health, the UCL Comprehensive Clinical Trials Unit, and the UCL Division of Medicine, played a part in this trial.

Credit: 
University College London

80% of sexual abuse victims in Spain who seek public compensation receive nothing

European Union law rules that Member States must provide fair and appropriate compensation for victims of sexual offences. In some countries, few victims receive any financial compensation, or often the amount received is very low. According to figures from the Spanish Government's Ministry of Finance, obtained by professor of Criminal Law at the UOC, Josep M. Tamarit, between 1998 and 2018 in Spain some 1,356 applications for public compensation were made, of which 272 were favourably settled. "During these two decades, only 20% of the compensation requested was granted. In other words, an average of 13 grants of 1,375 euros per person were paid out," revealed the expert.

Tamarit, the lead researcher on victimization in the UOC's VICRIM group, is involved in the European project FAIRCOM along with academics from other universities and NGOs from Spain, the Netherlands, Italy, Greece and Latvia. The project aims to improve the chances of victims of sexual offences to get fair and effective compensation. In the context of this research, the expert managed to ascertain that even though in Spain there is the possibility of applying for this compensation, in accordance with Law 35/1995, victims are faced with a number of obstacles to obtaining it.

"The figures show that in Spain there are few applications, and this is mainly due to the fact that not all the victims are properly informed about the option of making a claim," explained Tamarit. And in the case of the people who do apply for public compensation, it is often refused.

The criminal process in Spain

The main route to getting compensation is the criminal process. "If the aggressor has been identified, judged and sentenced, the court imposes in its ruling the obligation to pay compensation to the victim, who can apply for it if they have taken part in person in the proceedings or, in Spanish law, it can also be requested by the Public Prosecution Service," explained Tamarit. "The procedures for making a claim can be very long and complicated. The compensation awarded very often does not reach the victim because the offender has no resources or because the judicial system is incapable of executing the sentences," the expert added.

For the cases in which compensation cannot be made effective, Tamarit explained that the European states have established compensation mechanisms from public funds, based on the idea that the State must assume its duty to protect its citizens from crime. The payments are made as a symbol of recognition, public sympathy, and social solidarity with the victims. He said: "In Spain, the system of public compensation for victims of violent crimes and crimes against sexual freedom is managed by the Ministry of Finance, which takes a very restrictive approach, as shown by the figures."

12 good practices to guarantee compensation

Within the framework of the FAIRCOM project, funded by the European Union, the experts are drawing up a series of resources aimed at providing professionals and institutions with the tools to improve current legislation and practices. Among the first results, they concluded that Member States should take measures to ensure that the compensation awarded by the court is actually available to the victim, and that the public compensation systems have an effective impact on the victims who need it.

In their e-book State and Offender Compensation of Victims of Sexual Violence: Survey, Good Practices and Recommendations, the experts involved in the project recommend various good practices:

1. A public body should be responsible for obtaining the compensation awarded by the courts from the offender. In the Netherlands, this task is the responsibility of the Central Judicial Collection Agency (CJCA), which recovers up to 70% of the compensation awarded from offenders.

2. This could be complemented by an advance payment by the State, whereby if the compensation granted is advanced partially or in full to the victims in the event of the (partial) insolvency of the offender, the State can take recourse against the offender to recover this amount.

3. An effective and easy-to-follow procedure needs to be put in place. Article 16 of the Victims' Rights Directive obliges Member States to ensure that victims can obtain a decision on compensation by the offender within a reasonable time frame during the criminal proceeding. States should provide an alternative to civil proceedings, as these are currently ineffective in obtaining compensation from the offender, especially in the case of sexual offences.

4. State-funded lawyers and/or other forms of legal aid should be available to the victims of sexual offences who enter criminal proceedings, especially at the start of the process.

5. No court fee should be charged to extend access to compensation.

6. With regard to compensation by the State, it is recommended that this type of compensation is made available to all victims of sexual offences, including those that do not imply 'violence' in their usual connotation, such as online sex offences.

7. Specific attention should be paid to minors who suffer sexual abuse, taking into account the problem of domestic victimization and arbitrating procedures to ensure that the amount of compensation will meet the needs of underage victims, or that they will receive it when they reach adult age.

8. State compensation must be available, regardless of the outcome of criminal proceedings. Having to wait for the final decision of a criminal trial can lead to disproportionate waiting times, as most criminal proceedings take many years and consequently the situation places an unacceptable burden on the victims.

9. State compensation should be available in cases where the offender is not known, not prosecuted or not sentenced. A victim is no less a victim in these cases (UN Declaration of Basic Principles, 1985; European Convention on the Compensation of Victims of Violent Crimes (1983).

10. The deadline to apply for state compensation must be long and flexible enough to allow access to justice. It is revealing how the research shows that victims of sexual offences in the Netherlands apply for compensation on average about six years after the event. In the case of underage victims, calculating the deadline for applying for public compensation should begin when they reach adult age.

11. The decision-making authority should be an independent entity.

12. Countries should take into account the framework established by the European Court of Justice regarding the amounts of compensation. These amounts should not be purely symbolic or manifestly insufficient, and they should compensate, to the appropriate extent, the suffering to which the victims have been exposed. If fixed amounts are used, they should vary according to the severity of the violence suffered, and also to avoid a manifestly insufficient amount being awarded in view of the circumstances of a specific case.

To develop this good practice manual, the researchers undertook a study of the legal documents and instruments of European policy. The compensation schemes of the five participating countries were compared, using the descriptions of the compensation systems of the European e-Justice Portal. The content was validated and complemented with compensation experts from the participating countries and project partners. In addition, workshops were held in each participating country for professionals working with victims of sexual violence to discuss good practices and potential improvements.

Credit: 
Universitat Oberta de Catalunya (UOC)

Reconstructing historical typhoons from a 142-year record

image: Photo of a weather map when a typhoon hit Japan on 30 August 1896. Now archived in the Taiwan Central Weather Bureau (Photo: Hisayuki Kubota).

Image: 
Hisayuki Kubota

A team of scientists has, for the first time, identified landfalls of tropical cyclones (TCs) in Japan for the period from 1877 to 2019; this knowledge will help prepare for future TC disasters.

In recent years strong TCs have been making landfalls in Japan, such as Typhoon Jebi in 2018, which severely hit the Kinki region, and Typhoon Hagibis in 2019, which severely hit eastern Japan. While Japan has suffered from a number of TC impacts throughout its history, meteorological data for these events has been sparse.

The team, including Specially Appointed Associate Professor Hisayuki Kubota of the Faculty of Science, Hokkaido University, investigated TC activity over the western North Pacific and TC landfalls in Japan by analyzing a combination of TC tracking and meteorological data observed at weather stations and lighthouses, including rescued and recovered historical observations.

The team has collected and recovered TC track and landfall data and meteorological observations in the mid-19th century and later through an approach that rescues, collects and digitizes weather data across the world that has been stored away and often forgotten. To give the data useful consistency, the team developed a new, unified definition for TCs, based on minimum pressure.

According to their analysis, TC landfall locations tend to shift to the northeast and then southwest regions of Japan at roughly 100-year intervals. The analysis also shows that annual TC landfall numbers and their intensities have been increasing in recent years, while noting that these increases may be part of an oscillated fluctuation operating on interdecadal time scales.

The landfall numbers were relatively small in the late 20th century, and larger at other times. The Tohoku and Hokkaido regions, which experienced small numbers of TC landfalls in the late 20th century, may experience more landfalls in the future.

Japan's first official meteorological observation was conducted in Hakodate, Hokkaido, in 1872. There is very little earlier meteorological data obtained by meteorological instruments at terrestrial stations, which makes it difficult to perform long-term meteorological variability analyses. In a new approach, the team focused on foreign ship log weather records from the mid-19th century made with meteorological instruments on vessels sailing through East- and Southeast Asian waters.

The team used records from the US Navy expedition fleet to Japan led by Commodore Matthew C. Perry and from British Navy ships that also sailed to Japan to accurately identify the track of a TC moving over the ocean around the Okinawa Islands from 21 to 25 July 1853, and the track of a TC moving north over the East China Sea from 15 to 16 August 1863.

The results of the study show for the first time the usefulness of such marine data in identifying weather patterns after the mid-19th century in Asia, where there is much less meteorological data for that time period compared with Western countries. "It is projected that stronger TCs will hit Japan in the future due to global warming. The long-term data from our research is indispensable for knowing the variabilities of TC activities in the past and to prepare for future TCs," says Hisayuki Kubota.

Credit: 
Hokkaido University